复星医药膦甲酸钠注射液获注册批准

Core Viewpoint - Fosun Pharma's subsidiary, Guilin Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the drug registration of Sodium Foscarnet Injection, aimed at treating AIDS patients with cytomegalovirus retinitis and immunocompromised patients with acyclovir-resistant herpes simplex virus infections [1] Group 1 - The approved indication for Sodium Foscarnet Injection includes treatment for cytomegalovirus retinitis in AIDS patients [1] - The drug is also indicated for immunocompromised patients suffering from acyclovir-resistant herpes simplex virus infections [1]